Headlines

GE Healthcare (GEHC) Q4 2025 (USD): EPS 1.44 (exp. 1.40), Revenue 5.7bln (exp. 5.61bln)

Newsquawk Staff ·

GUIDANCE

  • FY EPS seen between 4.95-5.15 view (exp. 4.94)
  • Expects 2026 tariff impact to be lower than 2025, based on current rates

What it means

GE Healthcare's Q4 2025 results show a slight EPS beat against expectations, alongside revenue that also exceeds forecasts albeit by a narrower margin. The guidance for FY EPS suggests a modestly stronger outlook compared to consensus, while the reduced tariff impact projected for 2026 may enhance profitability, which could be positive for sentiment in GE's stock and its market sector.

Related headlines